Seoul, South Korea

Hee-jung Chun

This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hee-jung Chun. Retrieved from https://idiyas.com/inventor/hee-jung-chun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hee-jung Chun: Innovator in Pharmaceutical Chemistry

Introduction

Hee-jung Chun is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on phenoxypropanol derivatives.

Latest Patents

Hee-jung Chun holds a patent for a novel phenoxypropanol derivative and pharmaceutical composition, which is represented by the structure of Chemical Formula I. This invention includes a racemate, a pharmaceutically acceptable salt, a solvate, and a hydrate. The derivative is designed for blocking T-type calcium channels and/or TREK channels, which can be beneficial in preventing and treating associated diseases. He has 1 patent to his name.

Career Highlights

Chun is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development. His work has been instrumental in advancing the understanding of calcium channels and their implications in various medical conditions.

Collaborations

He has collaborated with notable colleagues, including Eun-Joo Roh and Kye-Jung Shin, who have contributed to his research endeavors.

Conclusion

Hee-jung Chun's innovative work in pharmaceutical chemistry exemplifies the impact of research on medical advancements. His contributions continue to pave the way for new treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…